Influence of galantamine on vasomotor reactivity in alzheimer's disease and vascular dementia due to cerebral microangiopathy

Stroke

Volumn 38, Issue 12, 2007, Pages 3186-3192

  Bär, Karl Jürgen ^a   Boettger, Michael Karl ^a   Seidler, Nicole ^a   Mentzel, Hans Joachim ^a   Terborg, Christoph ^a   Sauer, Heinrich ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Alzheimer's disease; Autonomic nervous system; Dementia; Near infrared spectroscopy; Transcranial Doppler sonography

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GALANTAMINE; HEMOGLOBIN; OXYHEMOGLOBIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROVASCULAR DISEASE; CHOLINERGIC ACTIVITY; CLINICAL ARTICLE; DOPPLER ECHOGRAPHY; DRUG EFFECT; FEMALE; FRONTAL CORTEX; HUMAN; MALE; MICROANGIOPATHY; MIDDLE CEREBRAL ARTERY; MULTIINFARCT DEMENTIA; NEAR INFRARED SPECTROSCOPY; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; VASOMOTOR REFLEX;

ACETYLCHOLINESTERASE; ADULT; AGED; ALZHEIMER DISEASE; CARBON DIOXIDE; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; CHOLINESTERASE INHIBITORS; DEMENTIA, VASCULAR; FEMALE; GALANTAMINE; HUMANS; MALE; MIDDLE AGED; NERVOUS SYSTEM; SPECTROSCOPY, NEAR-INFRARED; ULTRASONOGRAPHY, DOPPLER;

EID: 36448974220     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.492033     Document Type: Article

References (39)

1. Alzheimer A Über eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiatrie Psych Ger Med. 1907;146-148.
2. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
3. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci. 2004;5:347-360.
4. de la Torre JC, Mussivand T. Can disturbed brain microcirculation cause Alzheimer's disease? Neurol Res. 1993;15:146-153.
5. Iadecola C, Zhang F, Niwa K, Eckman C, Turner SK, Fischer E, Younkin S, Borchelt DR, Hsiao KK, Carlson GA. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci. 1999;2:157-161.
6. Tanzi RE, Moir RD, Wagner SL. Clearance of Alzheimer's Abeta peptide: the many roads to perdition. Neuron. 2004;43:605-608.
7. Wu Z, Guo H, Chow N, Sallstrom J, Bell RD, Deane R, Brooks AI, Kangala S, Rubio A, Sagare A, Liu D, Li F, Armstrong D, Gasiewicz T, Zidovetzki R, Song X, Hofman F, Zlokovic BV. Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease. Nat Med. 2005;11:959-965.
8. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Oden A, Svanborg A. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347:1141-1145.
9. Buee L, Hof PR, Bouras C, Delacourte A, Perl DP, Morrison JH, Fillit HM. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol (Berl). 1994;87:469-480.
10. Lassen NA. Control of cerebral circulation in health and disease. Circ Res. 1974;34:749-760.
11. Faraci FM, Heistad DD. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev. 1998;78:53-97.
12. Roman GC, Kalaria RN. Vascular determinants of cholinergic deficits in Alzheimer's disease and vascular dementia. Neurobiol Aging. 2006;27:1769-1785.
13. Francis PT, Palmer AM, Snape M, Wilcock GK. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry. 1999;66:137-147.
14. Terborg C, Gora F, Weiller C, Rother J. Reduced vasomotor reactivity in cerebral microangiopathy: a study with near-infrared spectroscopy and transcranial Doppler sonography. Stroke. 2000;31:924-929.
15. Burns A, O'Brien J. Clinical practise with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology. J Psychopharmacol. 2006;20:732-755.
16. Samochocki M, Höffle A, Fehrenbacher A, Jostock R, Ludwig J, Christner C, Radina M, Zerlin M, Ullmer C, Perreira EF, Lubbert H, Albuquerque EX, Maelicke A. Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not muscarinic acetylcholine receptors. J Pharmacol Exp Ther. 2003;305:1024-1036.
17. Rosengarten B, Paulsen S, Molnar S, Kaschel R, Gallhofer B, Kaps M. Acetylcholine esterase inhibitor donepezil improves dynamic cerebrovascular regulation in Alzheimer patients. J Neurol. 2006;253:58-64.
18. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state.' A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
19. Wechsler D. The Wechsler Memory Scale-Revised. New York: Psychological Corp. 1987.
20. Oswald WD, Fleischmann UM. Psychometrics in aging and dementia: advances in geropsychological assessments. Arch Gerontol Geriatr. 1985;4:299-309.
21. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412-2414.
22. Erkinjuntti T. Clinical criteria for vascular dementia: the NINDS-AIREN criteria. Dementia. 1994;5:189-192.
23. Terborg C, Birkner T, Schack B, Weiller C, Rother J. Noninvasive monitoring of cerebral oxygenation during vasomotor reactivity tests by a new near-infrared spectroscopy device. Cerebrovasc Dis. 2003;16:36-41.
24. Terborg C, Bramer S, Weiller C, Rother J. Short-term effect of cigarette smoking on CO2-induced vasomotor reactivity in man. J Neurol Sci. 2002;205:15-20.
25. Hetzel A, Braune S, Guschlbauer B, Dohms K. CO2 reactivity testing without blood pressure monitoring? Stroke. 1999;30:398-401.
26. Mantyla R, Erkinjuntti T, Salonen O, Aronen HJ, Peltonen T, Pohjasvaara T, Standertskjold-Nordenstam CG. Variable agreement between visual rating scales for white matter hyperintensities on MRI. Comparison of 13 rating scales in a poststroke cohort. Stroke. 1997;28:1614-1623.
27. Johnson KA, Albert MS. Perfusion abnormalities in prodromal AD. Neurobiol Aging. 2000;21:289-292.
28. Kogure D, Matsuda H, Ohnishi T, Asada T, Uno M, Kunihiro T, Nakano S, Takasaki M. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med. 2000;41:1155-1162.
29. Tohgi H, Yonezawa H, Takahashi S, Sato N, Kato E, Kudo M, Hatano K, Sasaki T. Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer's type and vascular dementia with deep white matter changes. Neuroradiology. 1998;40:131-137.
30. Franceschi M, Alberoni M, Bressi S, Canal N, Comi G, Fazio F, Grassi F, Perani D, Volonte MA. Correlations between cognitive impairment, middle cerebral artery flow velocity and cortical glucose metabolism in the early phase of Alzheimer's disease. Dementia. 1995;6:32-38.
31. Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, Breteler MM. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol. 2005;57:789-794.
32. Allan LM, Ballard CG, Allen J, Murray A, Davidson AW, McKeith IG, Kenny RA. Autonomic dysfunction in dementia. J Neurol Neurosurg Psychiatry. 2007;78:671-677.
33. Estevez AY, Phillis JW. Hypercapnia-induced increases in cerebral blood flow: roles of adenosine, nitric oxide and cortical arousal. Brain Res. 1997;758:1-8.
34. Kuwubara Y, Ichiya Y, Otsuka M, Masuda K, Ichimiya A, Fujishima M. Cerebrovascular responsiveness to hypercapnia in Alzheimer's disease and vascular dementia of the Binswanger type. Stroke. 1992;23:594-598.
35. Oishi M, Mochizuki Y, Takasu T. Blood flow differences between leukoaraiosis with and without lacunar infarction. Can J Neurol Sci. 1998;25:70-75.
36. Niwa K, Younkin C, Ebeling C, Turner SK, Westaway D, Younkin S, Ashe KH, Carlson GA, Iadecola C. Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. Proc Natl Acad Sci U S A. 2000;97:9735-9740.
37. Pirchl M, Marksteiner J, Humpel C. Effects of acidosis on brain capillary endothelial cells and cholinergic neurons: relevance to vascular dementia and Alzheimer's disease. Neurol Res. 2006;28:657-664.
38. Kastrup A, Dichgans J, Niemeier M, Schabet M. Changes of cerebrovascular CO2 reactivity during normal aging. Stroke. 1998;29:1311-1314.
39. Hlastala MP. Diffusing capacity heterogeneity. In: Farhi LE, Tenney SM, eds. Handbook of Physiology, Section 3: the Respiratory System, vol IV. Bethesda, MD: American Physiological Society; 1986:217.